Oyster Point Pharma Inc (OYST) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oyster Point Pharma Inc   (NASDAQ: OYST)


Oyster Point Pharma Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oyster Point Pharma Inc's ROI in the third quarter of 2022?
Oyster Point Pharma Inc recorded a cumulative net loss of $-235 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -174.15%.

Within the Healthcare sector 1008 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 5266.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM -21.68 % -10.72 % -13.6 % -5.57 % 0.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 80 113 154 194 180
Return On Investment (TTM) -174.15 % -135.07 % -110.83 % -91.43 % -46.87 %
OYST's Overall Ranking # 5266 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -15.6 % -5.77 % -2.49 % 1 % -3.79 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -235 -216 -188 -159 -81

OYST Company Profile >> Back to OYST Roi Comparisons >> See Annual OYST Return On Investment



Return On Investment OYST's Ranking
Within: No.
Industry # 156
Sector # 1009
Overall # 5266

Return On Investment Statistics
High Average Low
457.62 %
65.28 %
-174.15 %
(Dec 31 2019)   (Sep 30 2022)







Financial Statements
Oyster Point Pharma Inc's III. Quarter Investments $ 80 Millions OYST's Balance sheet
Oyster Point Pharma Inc's III. Quarter Income $ -37 Millions Quarterly OYST's Income Statement
OYST's Income by Division See OYST's Income by Division


OYST Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019

Total Investments in Millions 194 187 138 0 0
Y / Y Investment Growth 3.68 % 35.64 % - - -
Net Income in Millions -101 -71 -46 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -51.94 % -37.73 % -33.17 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OYST's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OYST's Competitors
Subscribers only: Roi for Oyster Point Pharma Inc's Suppliers
Subscribers only: Return On Investment for OYST's Customers

Other Ratios
OYST's Roa OYST's Inventory Turnover Ratio OYST's Growth Rates OYST's Dividend Statistics
OYST's Profitability Ratios OYST's Asset Turnover Ratio OYST's Dividend Growth
OYST's Roe OYST's Valuation Ratios OYST's Financial Strength Ratios OYST's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.